miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.
about
MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA.miR-638 suppresses DNA damage repair by targeting SMC1A expression in terminally differentiated cellsHigh expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer.Molecular approaches to potentiate cisplatin responsiveness in carcinoma therapeutics.Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer.miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer.MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2.Prognostic Implications of miR-302a/b/c/d in Human Gastric Cancer.Functional miRNAs in breast cancer drug resistance.Fentanyl inhibits proliferation and invasion via enhancing miR-302b expression in esophageal squamous cell carcinoma.MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers
P2860
Q33591783-E4FAB1B0-260D-4826-A8B6-8E27E3169032Q33838622-A6B6E533-C8D7-4839-9A5D-2281DE4A1AA2Q36316457-A7BB1218-3035-4A14-BFFA-CA826430C3FCQ37194235-184CAB05-DE8D-4C8D-BE17-49A5825AC38FQ37662154-5A2863CE-2196-40D6-8A5B-6A600066C34AQ39433258-FC8AB9C8-DF72-4177-A88A-3D1C7B9112BDQ41025296-3F821DEB-D76E-43AB-9892-0E5FF7D33144Q41472283-C02B38B7-FB3A-4C98-A1D5-A0F0EC8822A9Q42657433-90A5DE82-7D08-4BAD-BA5A-7A6F96C231A2Q50506385-9EA8DAA9-1625-4222-BA3C-D9B9FC94A509Q55000578-0D75532D-3E48-4475-8430-F7A5A3F2B82FQ55416925-92724C16-1A83-4730-A46D-66C5BF33F18AQ57106460-78F7AD8F-7F9C-4718-9BF4-265CF00DEB7E
P2860
miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
miR-302b enhances breast cance ...... cellular DNA damage response.
@ast
miR-302b enhances breast cance ...... cellular DNA damage response.
@en
type
label
miR-302b enhances breast cance ...... cellular DNA damage response.
@ast
miR-302b enhances breast cance ...... cellular DNA damage response.
@en
prefLabel
miR-302b enhances breast cance ...... cellular DNA damage response.
@ast
miR-302b enhances breast cance ...... cellular DNA damage response.
@en
P2093
P2860
P50
P356
P1433
P1476
miR-302b enhances breast cance ...... e cellular DNA damage response
@en
P2093
Carlo M Croce
Dario Palmieri
Douglas G Cheung
Marilena V Iorio
P2860
P304
P356
10.18632/ONCOTARGET.6381
P407
P577
2016-01-01T00:00:00Z